{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:45:56Z","timestamp":1794271556234,"version":"4.9.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["\\u00B7JCYJ20220531102202005"],"award-info":[{"award-number":["\\u00B7JCYJ20220531102202005"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["\\u00B72024A1515012118"],"award-info":[{"award-number":["\\u00B72024A1515012118"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.eclinm.2024.102859","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T11:09:35Z","timestamp":1728040175000},"page":"102859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Global, regional, and national prevalence of HIV-1 drug resistance in treatment-naive and treatment-experienced children and adolescents: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"77","author":[{"given":"Lingyun","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinsong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-7006","authenticated-orcid":false,"given":"Jiaye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/QAD.0000000000003194","article-title":"Effect of antiretroviral therapy care interruptions on mortality in children living with HIV","volume":"36","author":"Davies","year":"2022","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12098-021-04045-4","article-title":"Short-term adverse drug reactions to antiretroviral therapy in children with HIV: a cohort study","volume":"90","author":"Ray","year":"2023","journal-title":"Indian J Pediatr"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"S Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.eclinm.2024.102859_bib9","author":"Stanford University"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102859_bib14","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/jac\/dkw218","article-title":"Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa","volume":"71","author":"Boender","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAD.0b013e3283352ef1","article-title":"Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero","volume":"24","author":"Lidstr\u00f6m","year":"2010","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/aid.2009.0164","article-title":"Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda","volume":"26","author":"Towler","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/591503","article-title":"Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission","volume":"198","author":"Church","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib18","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/QAD.0b013e328344fedc","article-title":"Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine\/zidovudine prophylaxis","volume":"25","author":"Fogel","year":"2011","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1089\/aid.2015.0122","article-title":"Analysis of reverse transcriptase and protease genes of HIV for antiretroviral drug resistance in treatment-exposed Jamaican pediatrics","volume":"31","author":"Ramkissoon","year":"2015","journal-title":"AIDS Res Hum Retrovir"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jmv.20912","article-title":"Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure","volume":"79","author":"Lwembe","year":"2007","journal-title":"J\u00a0Med Virol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/cid\/ciw213","article-title":"Antiretroviral drug resistance among children and youth in the United States with perinatal HIV","volume":"63","author":"Van Dyke","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102859_bib22","first-page":"66","article-title":"Antiretroviral drug resistance in Brazilian children infected by human immunodeficiency virus type 1","volume":"4","author":"Bismara","year":"2012","journal-title":"J\u00a0Antivir Antiretrovir"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102859_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5144\/0256-4947.2012.565","article-title":"Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy","volume":"32","author":"Al Hajjar","year":"2012","journal-title":"Ann Saudi Med"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/599612","article-title":"Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV","volume":"49","author":"Chalermchockcharoenkit","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib25","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/cid\/civ058","article-title":"Antiretroviral treatment failure, drug resistance, and subtype diversity in the only pediatric HIV clinic in Rhode Island","volume":"60","author":"Rogo","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102859_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3851\/IMP3011","article-title":"Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing: final results of the PIANO study","volume":"21","author":"Tambuyzer","year":"2016","journal-title":"Antivir Ther"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib27","first-page":"511","article-title":"Characterisation of protease resistance mutations in a South African paediatric cohort with virological failure, 2011 - 2017","volume":"109","author":"Makatini","year":"2019","journal-title":"S\u00a0Afr Med J"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib28","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/jac\/dkaa002","article-title":"Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in Mali","volume":"75","author":"Brice","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2222-1808(15)60914-8","article-title":"Characterization of drug resistance mutations in ART-na\u00efve HIV-1 infected children in Northern Vietnam","volume":"5","author":"Phung","year":"2015","journal-title":"Asian Pac J Trop Dis"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib30","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/aid.2005.21.1031","article-title":"Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Cote d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission","volume":"21","author":"Toni","year":"2005","journal-title":"AIDS Res Hum Retrovir"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib31","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/genes12091314","article-title":"Characterizing HIV-1 genetic subtypes and drug resistance mutations among children, adolescents and pregnant women in Sierra Leone","volume":"12","author":"Yendewa","year":"2021","journal-title":"Genes"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144057","article-title":"Clinical, virologic, immunologic outcomes and emerging HIV drug resistance patterns in children and adolescents in public ART care in Zimbabwe","volume":"10","author":"Makadzange","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib33","first-page":"6","article-title":"Compromise of second-line antiretroviral therapy due to high rates of human immunodeficiency virus drug resistance in Mozambican treatment-experienced children with virologic failure","volume":"9","author":"Vaz","year":"2020","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102859_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1139\/gen-2020-0112","article-title":"Determination of reverse transcriptase inhibitor resistance mutations in HIV-1 infected children in C\u00f4te d'Ivoire","volume":"64","author":"Camara-Cisse","year":"2021","journal-title":"Genome"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/QAD.0000000000001273","article-title":"Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern","volume":"31","author":"Muri","year":"2017","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131994","article-title":"Development of nevirapine resistance in children exposed to the prevention of mother-to-child HIV-1 transmission programme in Maputo, Mozambique","volume":"10","author":"Antunes","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.meegid.2008.10.002","article-title":"Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure","volume":"9","author":"Dumans","year":"2009","journal-title":"Infect Genet Evol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib38","first-page":"104","article-title":"Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children","volume":"85","author":"Almeida","year":"2009","journal-title":"J\u00a0Pediatr"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib39","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/INF.0b013e31822db54c","article-title":"Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon","volume":"30","author":"Fokam","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102859_bib40","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/QAD.0000000000000261","article-title":"Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis","volume":"28","author":"Kuhn","year":"2014","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102859_bib41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1089\/aid.2011.0106","article-title":"Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa","volume":"28","author":"Green","year":"2012","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102859_bib42","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jac\/dkx025","article-title":"Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas","volume":"72","author":"Andrade","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib43","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/jac\/dkac407","article-title":"Drug resistance in children and adolescents with HIV in Panama","volume":"78","author":"Ventosa-Cubillo","year":"2023","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-6405-11-3","article-title":"Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort","volume":"11","author":"Pillay","year":"2014","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.eclinm.2024.102859_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104547","article-title":"Drug resistance in HIV-infected children living in rural South Africa: implications of an antiretroviral therapy initiated during the first year of life","volume":"129","author":"Beghin","year":"2020","journal-title":"J\u00a0Clin Virol"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102859_bib46","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/INF.0b013e3181e47609","article-title":"Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine","volume":"29","author":"Gupta","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib47","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/jac\/dkq234","article-title":"Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital","volume":"65","author":"Bratholm","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102859_bib48","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/jac\/dkr305","article-title":"Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain","volume":"66","author":"de Mulder","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/QAI.0b013e318229f2a2","article-title":"Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural China","volume":"58","author":"Zhao","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jac\/dkab430","article-title":"Drug resistance profiles and influencing factors among HIV-infected children and adolescents receiving long-term ART: a multicentre observational study in China","volume":"77","author":"Yan","year":"2022","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/QAI.0b013e3181fbcbf7","article-title":"Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children","volume":"56","author":"Ruel","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib52","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/INF.0b013e31827fb2d1","article-title":"Effectiveness of first-line antiretroviral therapy and acquired drug resistance among HIV-1-infected children in India","volume":"32","author":"Shet","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"14","key":"10.1016\/j.eclinm.2024.102859_bib53","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1089\/08892220152596579","article-title":"Emergence of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens","volume":"17","author":"Fitzgibbon","year":"2001","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.eclinm.2024.102859_bib54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jgar.2024.03.013","article-title":"Emergence of HIV-1 drug resistance mutations among children and adolescents undergoing prolonged antiretroviral therapy in Guangxi","volume":"37","author":"Pang","year":"2024","journal-title":"J\u00a0Glob Antimicrob Resist"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib55","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/aid.2006.0167","article-title":"Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India","volume":"23","author":"Kurle","year":"2007","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib56","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jac\/dkad010","article-title":"Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey","volume":"78","author":"Kamori","year":"2023","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102859_bib57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/aid.2016.0133","article-title":"Etravirine and rilpivirine drug resistance among HIV-1 subtype C infected children failing non-nucleoside reverse transcriptase inhibitor-based regimens in South India","volume":"33","author":"Saravanan","year":"2017","journal-title":"AIDS Res Hum Retrovir"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102859_bib58","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3851\/IMP1461","article-title":"Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina","volume":"14","author":"Vignoles","year":"2009","journal-title":"Antivir Ther"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102859_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/135965350200700410","article-title":"Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir\/lamivudine, zidovudine\/lamivudine or abacavir\/zidovudine, with or without nelfinavir (the PENTA 5 trial)","volume":"7","author":"Gibb","year":"2002","journal-title":"Antivir Ther"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib60","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1089\/aid.2013.0025","article-title":"Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines","volume":"29","author":"Coetzer","year":"2013","journal-title":"AIDS Res Hum Retrovir"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133452","article-title":"Factors associated with the development of drug resistance mutations in HIV-1 infected children failing protease inhibitor-based antiretroviral therapy in South Africa","volume":"10","author":"Rossouw","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102859_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jpids\/piad040","article-title":"Factors associated with viral suppression and drug resistance in children and adolescents living with HIV in care and treatment programs in southern Tanzania","volume":"12","author":"Khamadi","year":"2023","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102859_bib63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/1570162X17666191106111211","article-title":"The frequency of HIV-1 infection in Iranian children and determination of the transmitted drug resistance in treatment-na\u00efve children","volume":"17","author":"Jarchi","year":"2019","journal-title":"Curr HIV Res"},{"issue":"16","key":"10.1016\/j.eclinm.2024.102859_bib64","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/QAD.0000000000000814","article-title":"Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis","volume":"29","author":"Nelson","year":"2015","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib65","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/01.inf.0000190413.88671.92","article-title":"Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, C\u00f4te d'Ivoire","volume":"24","author":"Chaix","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcv.2003.08.001","article-title":"Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy","volume":"30","author":"Machado","year":"2004","journal-title":"J\u00a0Clin Virol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/v15010027","article-title":"High drug resistance levels compromise the control of HIV infection in pediatric and adult populations in Bata, Equatorial Guinea","volume":"15","author":"Rodr\u00edguez-Galet","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102859_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248835","article-title":"High drug resistance levels could compromise the control of HIV infection in paediatric and adolescent population in Kinshasa, the democratic republic of Congo","volume":"16","author":"Rubio-Garrido","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib69","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/v10020060","article-title":"High levels of dual-class drug resistance in HIV-infected children failing first-line antiretroviral therapy in southern Ethiopia","volume":"10","author":"Tadesse","year":"2018","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib70","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/INF.0000000000002270","article-title":"High levels of HIV-1 drug resistance in children who acquired HIV infection through mother to child transmission in the era of option B+, Haiti, 2013 to 2014","volume":"38","author":"Louis","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib71","article-title":"High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children","volume":"19","author":"Boerma","year":"2016","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102859_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006282","volume":"96","author":"Mossoro-Kpinde","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib73","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/QAD.0000000000002614","article-title":"High nonnucleoside reverse transcriptase inhibitor resistance levels in HIV-1-infected Zambian mother-infant pairs","volume":"34","author":"Bennett","year":"2020","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib74","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/jac\/dkz099","article-title":"High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO","volume":"74","author":"Mboumba Bouassa","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib75","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0000000000001553","article-title":"High prevalence of HIV drug resistance among newly diagnosed infants aged <18 months: results from a nationwide surveillance in Nigeria","volume":"77","author":"Inzaule","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0300","article-title":"High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the world health organization guidelines","volume":"29","author":"Kebe","year":"2013","journal-title":"AIDS Res Hum Retrovir"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102859_bib77","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1097\/INF.0000000000001575","article-title":"High rates of baseline drug resistance and Virologic failure among ART-naive HIV-infected children in Mali","volume":"36","author":"Crowell","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102859_bib78","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/INF.0000000000001203","article-title":"High rates of drug resistance among newly diagnosed HIV-infected children in the national prevention of mother-to-child transmission program in Togo","volume":"35","author":"Salou","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eclinm.2024.102859_bib79","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2334-12-317","article-title":"High viremia and low level of transmitted drug resistance in anti-retroviral therapy-na\u00efve perinatally-infected children and adolescents with HIV-1 subtype C infection","volume":"12","author":"Neogi","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097067","article-title":"High-level cross-resistance to didanosine observed in South African children failing an abacavir- or stavudine-based 1st-line regimen","volume":"9","author":"Steegen","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00002030-200401230-00013","article-title":"Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome","volume":"18","author":"Aboulker","year":"2004","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib82","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/aid.2015.0215","article-title":"HIV drug resistance among children initiating first-line antiretroviral treatment in Uganda","volume":"32","author":"Kityo","year":"2016","journal-title":"AIDS Res Hum Retrovir"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107074","article-title":"HIV drug resistance among patients experiencing antiretroviral therapy failure in Russia, 2019-2021","volume":"63","author":"Sivay","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102859_bib84","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3390\/v15102083","article-title":"HIV drug resistance patterns and characteristics associated with clinically significant drug resistance among children with virologic failure on antiretroviral treatment in Kenya: findings from the Opt4Kids randomized controlled trial","volume":"15","author":"Abuogi","year":"2023","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102859_bib85","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/aid.2017.0025","article-title":"HIV resistance and prevention of mother-to-child transmission regimen in HIV-infected infants in northern Tanzania","volume":"33","author":"Dow","year":"2017","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib86","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/088922204322996518","article-title":"HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda","volume":"20","author":"Servais","year":"2004","journal-title":"AIDS Res Hum Retrovir"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102859_bib87","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3390\/v14081761","article-title":"HIV-1 diversity and drug resistance in treatment-na\u00efve children and adolescents from Rio de Janeiro, Brazil","volume":"14","author":"de Azevedo","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib88","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e3283492180","article-title":"HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine","volume":"25","author":"Hunt","year":"2011","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000430","article-title":"HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis","volume":"8","author":"Zeh","year":"2011","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib90","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-1293.2010.00828.x","article-title":"HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"11","author":"Puthanakit","year":"2010","journal-title":"HIV Med"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102859_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071972","article-title":"HIV-1 drug-resistance surveillance among treatment-experienced and -na\u00efve patients after the implementation of antiretroviral therapy in Ghana","volume":"8","author":"Nii-Trebi","year":"2013","journal-title":"PLoS One"},{"issue":"5-6","key":"10.1016\/j.eclinm.2024.102859_bib92","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000477811","article-title":"HIV-1 subtype diversity and prevalence of primary drug resistance in a single-center pediatric cohort in Germany","volume":"59","author":"Neubert","year":"2016","journal-title":"Intervirology"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib93","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAI.0000000000002850","article-title":"HIV-1 treatment failure, drug resistance, and clinical outcomes in perinatally infected children and adolescents failing first-line antiretroviral therapy in western Kenya","volume":"89","author":"Nyandiko","year":"2022","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib94","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/cid\/cix698","article-title":"Human immunodeficiency virus (HIV) drug resistance in african infants and young children newly diagnosed with HIV: a multicountry analysis","volume":"65","author":"Jordan","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102859_bib95","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/cid\/cix1104","article-title":"Human immunodeficiency virus antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study","volume":"66","author":"Yeganeh","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102859_bib96","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/INF.0b013e31827f44ee","article-title":"Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants","volume":"32","author":"Fogel","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib97","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1128\/AAC.00910-06","article-title":"Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children","volume":"51","author":"Chaix","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/INF.0b013e31829e6b9f","article-title":"Long-term effectiveness of combination antiretroviral therapy and prevalence of HIV drug resistance in HIV-1-infected children and adolescents in Rwanda","volume":"33","author":"Mutwa","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib99","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/QAI.0b013e3182515730","article-title":"Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment","volume":"60","author":"Lehman","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102859_bib100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/aid.2014.0370","article-title":"Nevirapine resistance in previously nevirapine-#nexposed HIV-1-Infected Kenyan infants initiating early antiretroviral therapy","volume":"31","author":"Chohan","year":"2015","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.eclinm.2024.102859_bib101","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcv.2014.11.014","article-title":"Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure","volume":"62","author":"Fisher","year":"2015","journal-title":"J\u00a0Clin Virol"},{"issue":"13","key":"10.1016\/j.eclinm.2024.102859_bib102","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010176","article-title":"Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children","volume":"97","author":"Fokam","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102859_bib103","doi-asserted-by":"crossref","first-page":"178","DOI":"10.18683\/germs.2017.1124","article-title":"Observed HIV drug resistance associated mutations amongst na\u00efve immunocompetent children in Yaound\u00e9, Cameroon","volume":"7","author":"Ikomey","year":"2017","journal-title":"Germs"},{"key":"10.1016\/j.eclinm.2024.102859_bib104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1742-4690-6-85","article-title":"Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome","volume":"6","author":"Delaugerre","year":"2009","journal-title":"Retrovirology"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102859_bib105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.inf.0000164787.63237.0b","article-title":"Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life","volume":"24","author":"Kovacs","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eclinm.2024.102859_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.658186","article-title":"Phylogenetic and drug-resistance analysis of HIV-1 sequences from an extensive paediatric HIV-1 outbreak in Larkana, Pakistan","volume":"12","author":"Abidi","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib107","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/jac\/dky486","article-title":"Pre-treatment drug resistance and HIV-1 subtypes in infants from Argentina with and without exposure to antiretroviral drugs for prevention of mother-to-child transmission","volume":"74","author":"Aulicino","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib108","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/INF.0b013e3181a458f9","article-title":"Predictors of virologic failure and genotypic resistance mutation patterns in Thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"28","author":"Jittamala","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib109","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1111\/apa.15320","article-title":"Pretreatment HIV drug resistance predicts accumulation of new mutations in ART-naive Ugandan children","volume":"109","author":"Soeria-Atmadja","year":"2020","journal-title":"Acta Paediatr"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib110","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/jac\/dkx188","article-title":"Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children","volume":"72","author":"Kityo","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib111","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac102","article-title":"Pretreatment human immunodeficiency virus (HIV) drug resistance among treatment-naive infants newly diagnosed with HIV in 2016 in Namibia: results of a nationally representative study","volume":"9","author":"Jordan","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib112","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/v11090877","article-title":"Prevalence and correlates of pre-treatment HIV drug resistance among HIV-infected children in Ethiopia","volume":"11","author":"Tadesse","year":"2019","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102859_bib113","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/jac\/dkw039","article-title":"Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk","volume":"71","author":"Inzaule","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib114","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s12879-016-1968-2","article-title":"Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project","volume":"16","author":"Ngo-Giang-Huong","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/apc.2013.0308","article-title":"Prevalence and outcomes of recycling NNRTIs despite documented NNRTI resistance in HIV-infected children and youth","volume":"28","author":"Agwu","year":"2014","journal-title":"AIDS Patient Care STDS"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib116","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/jmv.20940","article-title":"Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children","volume":"79","author":"Delaugerre","year":"2007","journal-title":"J\u00a0Med Virol"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102859_bib117","first-page":"2344","article-title":"Prevalence and risk factors associated with resistance-associated mutations to etravirine in a cohort of perinatally HIV-infected children","volume":"68","author":"Contreras","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib118","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/jac\/dky203","article-title":"Prevalence of drug resistance in children recently diagnosed with HIV-1 infection in France (2006-17): impact on susceptibility to first-line strategies","volume":"73","author":"Frange","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib119","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.qai.0000225871.87456.e7","article-title":"Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State","volume":"42","author":"Karchava","year":"2006","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00126334-200303010-00008","article-title":"Prevalence of genotypic drug resistance among a cohort of HIV-infected newborns","volume":"32","author":"Parker","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib121","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/jac\/dkad334","article-title":"Prevalence of HIV drug resistance among adolescents receiving ART in Cameroon with low- or high-level viraemia","volume":"78","author":"Djiyou","year":"2023","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2024.102859_bib122","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1186\/s12879-019-4339-y","article-title":"Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13","volume":"19","author":"Hunt","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib123","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/v15020546","article-title":"Prevalence of HIV-1 natural polymorphisms and integrase-resistance-associated mutations in African children","volume":"15","author":"Fofana","year":"2023","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib124","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/135965350601100711","article-title":"A\u00a0randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial","volume":"11","author":"Green","year":"2006","journal-title":"Antivir Ther"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib125","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1089\/aid.2010.0205","article-title":"Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa","volume":"27","author":"Taylor","year":"2011","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.eclinm.2024.102859_bib126","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2019.20059","article-title":"The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study","volume":"149","author":"Compagno","year":"2019","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib127","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/jac\/dkac443","article-title":"Resistance is common in paediatric patients failing ART in South Africa","volume":"78","author":"Hunt","year":"2023","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib128","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/v16050696","article-title":"Resistance mutation patterns among HIV-1-Infected children and features of the program for prevention of mother-to-child transmission in Vietnam's central highlands and southern regions, 2017-2021","volume":"16","author":"Thu","year":"2024","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102859_bib129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1258\/ijsa.2008.008480","article-title":"Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China","volume":"20","author":"Han","year":"2009","journal-title":"Int J STD AIDS"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102859_bib130","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/jac\/dky300","article-title":"Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa","volume":"73","author":"Fofana","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib131","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00006454-200203000-00011","article-title":"Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor","volume":"21","author":"Servais","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib132","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1097\/INF.0b013e3181ba6c92","article-title":"Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure","volume":"28","author":"Vaz","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102859_bib133","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.arcped.2019.06.002","article-title":"Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali","volume":"26","author":"Sylla","year":"2019","journal-title":"Arch Pediatr"},{"issue":"15","key":"10.1016\/j.eclinm.2024.102859_bib134","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/00002030-200110190-00006","article-title":"Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)","volume":"15","author":"Eshleman","year":"2001","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0b013e31802b920e","article-title":"Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine","volume":"44","author":"Martinson","year":"2007","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib136","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/QAI.0000000000000568","article-title":"Single genome analysis for the detection of linked multiclass drug resistance mutations in HIV-1-Infected children after failure of protease inhibitor-based first-line therapy","volume":"69","author":"Lange","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102859_bib137","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/aid.2010.0346","article-title":"Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission","volume":"27","author":"Persaud","year":"2011","journal-title":"AIDS Res Hum Retrovir"},{"issue":"Suppl 4","key":"10.1016\/j.eclinm.2024.102859_bib138","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1093\/cid\/cis006","article-title":"Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique","volume":"54","author":"Vaz","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib139","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1089\/aid.2020.0272","article-title":"Surveillance of pretreatment drug resistance among HIV-infected children in Ibadan, Nigeria","volume":"37","author":"Olusola","year":"2021","journal-title":"AIDS Res Hum Retrovir"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib140","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1128\/JCM.40.12.4512-4519.2002","article-title":"Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy","volume":"40","author":"Brindeiro","year":"2002","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102859_bib141","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1089\/aid.2014.0354","article-title":"Transmitted drug resistance among recently diagnosed adults and children in S\u00e3o Paulo, Brazil","volume":"31","author":"Guimar\u00e3es","year":"2015","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.eclinm.2024.102859_bib142","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1874613601509010038","article-title":"Treatment-emergent mutations and resistance in HIV-infected children treated with Fosamprenavir-containing antiretroviral regimens","volume":"9","author":"Ross","year":"2015","journal-title":"Open AIDS J"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102859_bib143","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/jmv.25413","article-title":"Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug resistance and virological failure in children","volume":"91","author":"Gopalan","year":"2019","journal-title":"J\u00a0Med Virol"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102859_bib144","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/aid.2007.0264","article-title":"Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, C\u00f4te d'Ivoire","volume":"24","author":"Adj\u00e9-Tour\u00e9","year":"2008","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248642","article-title":"Virological failure and antiretroviral resistance among HIV-infected children after five years follow-up in the ANRS 12225-PEDIACAM cohort in Cameroon","volume":"16","author":"Tagnouokam-Ngoupo","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102859_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002432","article-title":"Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: observational analyses within the randomised ARROW trial","volume":"14","author":"Szubert","year":"2017","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib147","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/aid.2011.0035","article-title":"Virological response and resistance profiles after 18 to 30 months of first- or second-\/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic","volume":"28","author":"Charpentier","year":"2012","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib148","article-title":"Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir\/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort","volume":"20","author":"Amani-Bosse","year":"2017","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102859_bib149","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00126334-200106010-00001","article-title":"Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort","volume":"27","author":"Masquelier","year":"2001","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102859_bib151","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40471-021-00268-3","article-title":"HIV drug resistance in children and adolescents: always a challenge?","volume":"8","author":"Koay","year":"2021","journal-title":"Curr Epidemiol Rep"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102859_bib152","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jix089","article-title":"Impact of HIV drug resistance on HIV\/AIDS-associated mortality, new infections, and antiretroviral therapy program costs in Sub-Saharan Africa","volume":"215","author":"Phillips","year":"2017","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102859_bib154","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12981-023-00572-6","article-title":"Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review","volume":"20","author":"SeyedAlinaghi","year":"2023","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.eclinm.2024.102859_bib156","author":"Phillips"},{"issue":"Suppl 4","key":"10.1016\/j.eclinm.2024.102859_bib159","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1093\/cid\/cir1015","article-title":"Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries","volume":"54","author":"Sigaloff","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2024.102859_bib160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijid.2020.02.031","article-title":"HIV drug resistance early warning indicators in Ethiopia: variability at regional and health facility levels and trend over time","volume":"95","author":"Getaneh","year":"2020","journal-title":"Int J Infect Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024004383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024004383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:04:10Z","timestamp":1778904250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024004383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":148,"alternative-id":["S2589537024004383"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102859","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global, regional, and national prevalence of HIV-1 drug resistance in treatment-naive and treatment-experienced children and adolescents: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102859"}}